A methodology for assessing the risk profile of a life science company prior to valuation. The different valuation methods used for life science companies and products. How to calculate the value of a biotech or life science company with the Discounted Cash Flow method, comparables and exit valuation. How to use risk-adjusted Net Present Value (rNPV) to calculate the value of a pharmaceutical compound in development. How to structure the licensing deal between companies, covering issues such as milestone and royalty payments.

The Swiss Biotech Day is a premier biotechnology conference in Europe, attracting professionals from the global life sciences community. In 2024, it will once again provide a platform for networking, engaging discussions, and the exploration of advancements in R&D, manufacturing, data management, artificial intelligence, and innovative financing. International biotech delegations use the “Global Village” to strengthen their ties with Switzerland as a biotech hub and promote cross-border investments, public-private partnerships, research and development collaborations and exchange of talent.

BioTrinity is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

Asia Bio Partnering Forum will continue to build on its strong start and will gather biotech and pharma leaders from around the world with hundreds of emerging innovators across Asia Pacific to advance dealmaking in Asia. Asia Bio Partnering Forum will bring together over 500 innovators from key Asian markets with life science leaders from around the world to advance dealmaking across Asia. Meet one-to-one with innovative companies across Asia. Leverage informal networking opportunities to expand your network. Access the largest network of cross-border partners to accelerate your global partnering strategies. Find your partner of choice at the event’s active exhibit. This event presents a valuable opportunity to refine and broaden your partnering strategies across Asia. Don’t miss out to delve into the dynamic environment of one of the fastest-growing and most productive hubs for biotech and deal-making.

The 10th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core. The event brings together the CEOs and senior decision makers from the world's most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments - all geared at putting capital and ideas to work to help create the world's future medicines and improve patient outcomes.

Since 2006, BIO KOREA has been holding the International Convention every year for invigorating and growing the global bio-health industry. This year also, we are pleased to announce the 19th BIO KOREA will be held on May 8-10, 2024 at COEX, Seoul. Through various programs of BIO KOREA 2024 including Business Partnering, Exhibition, Conference, and Invest Fair, exchange the newest bio-health trends and technology as well as get the global expansion business opportunity with various international academics, professionals, and CEOs of the global bio-health field!

Online Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.

The Pharma Partnering EU Summit 2024 is one of the most prestigious physical events of 2024 in the EU for life science professionals. This platform brings together senior executives from different parts of the world, focused on Licensing, R&D Collaborations, Commercialisation & Distribution deals, Fundraising, Investing, Digital Health Alliances, M&A, Going Public as well as partnering opportunities in the broader aspects. The agenda is structured for the needs of Pharma & Biotech Senior Executives. The EU Summit 2024 aims to help companies to expand their network, put together deals and develop their business. The Summit also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.

BIO is where business and breakthroughs converge. Whether it’s across hemispheres or across the aisle, BIO brings the industry together to solve the most pressing issues facing our world. Attend innovative programming around therapeutic frontiers, policy, the business of biotech, regulatory updates, and the future of the biotech workforce.

The Redefining Early Stage Investments (RESI) conference series will come to Europe again connecting start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health. RESI caters to both seed and angel capital, and the early-stage firms who seek series A and B funding. Biotechgate listed companies can use the following codes for a 10% discount:

• 1-day in person: BTG1DAY
• 2-day virtual: BTG2DAY
• 3-day: BTG3DAY

BioTechX USA is the leading digital transformation event for precision medicine on the East Coast covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. In 2024, our 2-day event will host 1500 leaders in the field, 100 sponsors, 100 start-ups and 300 speakers from the top 50 pharmaceutical companies, biotechs, healthcare systems and academic groups, creating endless networking opportunities. For 50% off delegate tickets, use code BTG50 Free VIP guest link for Biotechgate members that fall into the buy side part of the conference

BioTechX Europe is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. With 16 tracks of high-level content and a poster presentation session, the event covers everything from the use and management of multiomic data to the development of personalised therapies as well as covering the actual generation of the data. In 2024 BioTechX will return to Basel, the pharma hub of Europe, this time with 3500 global executives, 400 speakers and 50 start-ups all under one roof, bridging the gap between pharma, academia and clinicians. Don't miss Europe's largest biotechnology congress for pharma, healthcare and partners. For 50% off delegate tickets, use code BTG50 Free VIP guest link for Biotechgate members that fall into the buy side part of the conference